Etiology of anemia in patients with advanced heart failure.

[1]  M. Anastasiou-Nana,et al.  Prevalence and prognostic significance of anemia in patients with congestive heart failure treated with standard vs high doses of enalapril. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  M. Cazzola,et al.  Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. , 2005, European heart journal.

[3]  M. Anastasiou-Nana,et al.  Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone. , 2005, The American journal of cardiology.

[4]  A. Collins,et al.  Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population. , 2004, Journal of cardiac failure.

[5]  J. McMurray,et al.  Anemia and Its Relationship to Clinical Outcome in Heart Failure , 2004, Circulation.

[6]  P. Poole‐Wilson,et al.  Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial , 2004 .

[7]  M. Anastasiou-Nana,et al.  Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study. , 2004, Chest.

[8]  G. Iotti,et al.  Body iron status in critically ill patients: significance of serum ferritin , 2004, Intensive Care Medicine.

[9]  C. O'connor,et al.  Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. , 2003, The American journal of cardiology.

[10]  P. Ponikowski,et al.  Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. , 2003, International journal of cardiology.

[11]  P. Ponikowski,et al.  Effect of anemia on exercise tolerance in chronic heart failure in men. , 2003, The American journal of cardiology.

[12]  Harlan M Krumholz,et al.  The prognostic importance of anemia in patients with heart failure. , 2003, The American journal of medicine.

[13]  C. Lang,et al.  Effect of Erythropoietin on Exercise Capacity in Patients With Moderate to Severe Chronic Heart Failure , 2003, Circulation.

[14]  Paul W Armstrong,et al.  Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure , 2003, Circulation.

[15]  L. Lund,et al.  Hemodilution Is Common in Patients With Advanced Heart Failure , 2003, Circulation.

[16]  K. Witte,et al.  Nutritional abnormalities contributing to cachexia in chronic illness. , 2002, International journal of cardiology.

[17]  C. Jurkovitz,et al.  Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. , 2002, Journal of the American Society of Nephrology : JASN.

[18]  G. Fonarow,et al.  Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. , 2002, Journal of the American College of Cardiology.

[19]  G. Weiss.  Pathogenesis and treatment of anaemia of chronic disease. , 2002, Blood reviews.

[20]  A. Struthers,et al.  Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes? , 2002, Heart.

[21]  P. Iversen,et al.  Decreased hematopoiesis in bone marrow of mice with congestive heart failure. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[22]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[23]  W. Rand,et al.  Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. , 2001, Journal of the American College of Cardiology.

[24]  I. Shapira,et al.  The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. , 2001, Journal of the American College of Cardiology.

[25]  P. Mohacsi,et al.  Serum erythropoietin in heart failure patients treated with ACE‐inhibitors or AT1 antagonists , 2000, European journal of heart failure.

[26]  I. Shapira,et al.  The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. , 2000, Journal of the American College of Cardiology.

[27]  R. Means,et al.  Advances in the anemia of chronic disease. , 1999, International journal of hematology.

[28]  B. Bozkurt,et al.  An overview of tumor necrosis factor α and the failing human heart , 1999 .

[29]  A. Tefferi,et al.  Measurement of blood volume and red cell mass: re-examination of 51Cr and 125I methods. , 1996, Blood cells, molecules & diseases.

[30]  P. Poole‐Wilson,et al.  Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. , 1993, British heart journal.

[31]  J. McNeil,et al.  Adverse effects of low‐dose aspirin in a healthy elderly population , 1993, Clinical pharmacology and therapeutics.